Quality of Life in Adolescent Boys with Idiopathic Short Stature: Positive Impact of Growth Hormone and Aromatase Inhibitors.

Journal: Hormone research in paediatrics
PMID: 30820008

Abstract

BACKGROUND: The combination of growth hormone (GH) and aromatase inhibitors (AI) improves linear growth in severely short adolescent boys; however, the effects of this intervention on quality of life (QoL) are unknown. This study assesses whether GH, AI, or their combination impacts the QoL of adolescent males with idiopathic short stature (ISS) from both the adolescent and the parent perspective.

Authors

  • Monika Bullinger
    University Clinic Hamburg-Eppendorf, Hamburg, Germany.
  • Janika Bloemeke
    University Clinic Hamburg-Eppendorf, Hamburg, Germany, j.bloemeke@uke.de.
  • Veronica Mericq
    Division of Endocrinology, University of Santiago, Santiago, Chile.
  • Rachel Sommer
    University Clinic Hamburg-Eppendorf, Hamburg, Germany.
  • Xiemena Gaete
    Division of Endocrinology, University of Santiago, Santiago, Chile.
  • Judith L Ross
    Division of Endocrinology, Nemours Children's Health System, Philadelphia, Pennsylvania, USA.
  • Y Miles Yu
    Division of Endocrinology, Nemours Children's Health System, Orlando, Florida, USA.
  • Joseph Permuy
    Division of Endocrinology, Nemours Children's Health System, Jacksonville, Florida, USA.
  • Priscila Gagliardi
    Division of Endocrinology, Nemours Children's Health System, Jacksonville, Florida, USA.
  • Y Ligeia Damaso
    Division of Endocrinology, Nemours Children's Health System, Jacksonville, Florida, USA.
  • Nelly Mauras
    Division of Endocrinology, Nemours Children's Health System, Jacksonville, Florida, USA.

Keywords

External Resources

Popular Topics
Recent Journals